# Bikanta

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bikanta

- Industry: Medical Devices & Equipment
- Headquarters: Newark, US
- Website: www.bikanta.com
- Total disclosed funding: $0.1M
- Latest round: Seed (Jun 1, 2014)
- Investors on record: 1

## About

Bikanta is a biotechnology company that develops advanced therapies for various medical conditions, focusing on innovative biomolecules and effective drug delivery systems to enhance patient outcomes.Founded in 2013 in Newark, US, Bikanta specializes in innovative biotechnological solutions. The company participated in a Seed funding round in June 2014, raising USD 0.12 mn led by Y Combinator. No pivots or changes in operations have been noted since its inception, and there are no references to subsidiaries or parent companies.Bikanta specializes in advanced biotechnological solutions, with a focus on the development and commercialization of innovative therapies. Their core offerings include proprietary biomolecules and drug delivery systems aimed at treating conditions such as cancer, regenerative medicine, and immune modulation. Serving a diverse clientele including research institutions and pharmaceutical companies, Bikanta continues to expand its product line to meet unmet medical needs across North America, Europe, and parts of Asia.Bikanta generates revenue primarily through strategic partnerships and B2B transactions with healthcare institutions and pharmaceutical companies. Their model involves direct negotiations to establish tailored agreements, including licensing and collaborative research. Flagship products are priced at a premium due to their advanced capabilities, ensuring competitiveness while supporting ongoing innovations. The company emphasizes long-term partnerships with a dedicated client base to capitalize on the demand for biotechnological solutions.Bikanta's strategy for future growth includes the design and launch of new products aimed at addressing specific medical conditions, although specific release dates are not provided. The company plans to expand into additional markets, targeting regions in Asia and Europe by 2025. Recent funding from the Seed round in June 2014 will be utilized to support these initiatives and further develop their product lines, enhancing their market presence.

## Funding rounds

- Seed, Jun 1, 2014, $0.1M — Y Combinator

## Investors

- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Seed